Dr. Thomas James Avallone, MD

Dr. Avallone practices at UCSD Ambulatory Surgery Center, LLC in La Jolla, California.

Dr. Avallone's NPI, 1679865950, was assigned on May 5, 2011. Dr. Avallone graduated from LSU Health Shreveport School of Medicine in 2011. Dr. Avallone holds California license A147199.

Dr. Avallone's primary practice is UCSD Ambulatory Surgery Center, LLC, at 4120 La Jolla Village Dr, La Jolla, CA 92037 in San Diego County. The practice phone is (858) 657-0055.

Dr. Avallone's primary practice is UCSD Ambulatory Surgery Center, LLC in La Jolla, California. Dr. Avallone is also affiliated with Sharp Coronado Hospital. Dmand AI also links Dr. Avallone to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Avallone practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Avallone's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Avallone is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Avallone's licenses on file in 2 states: California and Nebraska.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Avallone treats.

CMS data shows 3,058 Medicare services from Dr. Avallone across 20 procedure codes in 2024, for 703 Medicare patients. Medicare paid $233,937 for them.

CMS counts 703 Medicare patients who saw Dr. Avallone in 2024. The largest group is 75 to 84, with 300 patients. 69% of them have high cholesterol, and 65% have high blood pressure. Their average risk score is 1.03, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Avallone's median patient age at 77, with 57% women.

In 2024, Dr. Avallone wrote 979 Medicare Part D claims for 321 patients. 64% of them were for generic drugs. CMS names the drug for 881 of them, across 20 drugs with 11 or more claims each, at $115,210 in total drug cost. In 2023, CMS named 2,219 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Avallone for performance year 2024, reported as part of a group. Dr. Avallone accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 156 procedures of cataract surgery by Dr. Avallone, more than 80% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Avallone. Dr. Avallone's most frequent co-authors are Jeremy Mark Burnham, MD and Anne M. Hollister, MD.

Dmand AI links Dr. Avallone to 1 clinical trial. Conditions studied include Myopia and Refractive Errors.

CMS Open Payments shows 146 general payments to Dr. Avallone from 24 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 97% of the total. Alcon Laboratories Inc paid the most, $1,182.

Dmand AI lists 2 awards for Dr. Avallone, most recently Chief Resident in 2015.

Dr. Avallone graduated from LSU Health Shreveport School of Medicine in 2011. Dr. Avallone is a member of AAO, American Glaucoma Society and ASCRS.

Dr. Avallone is in network with 9 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.